CALL FOR IMMEDIATE ACTION!
In December 2017, the FDA issued a draft guidance that would revoke CPG 400.400 and replace it with an updated risk-based policy
. The American Association of Homeopathic Pharmacists (AAHP) is working with the FDA. This partnership will ensure key aspects of the CPG 400.400
into the new draft guidance. It will also clarify the process of homeopathic products regulation.
The purpose of the new draft guidance is to ensure that consumers continue to gain access to homeopathic remedies
in accordance with
the highest quality and safety standards
The commenting period has been extended to May 21, 2018. Act now and
Over the next few days before the May 21 deadline, we need YOU to contact your politician with a newly drafted letter. This will educate our government officials and representatives on this important issue. With a joined effort, we are working to gain their support in favor of homeopathy.
page to find the appropriate letter.
As always - deep gratitude from the CHC for your continuous support!
Sincerely, The Board of Directors